The World Market for Anti-infectives Volume I: The World Market for Antifungal Medications

Attention: There is an updated edition available for this report.
 
   Single User - $2,500
   Hard Copy Mail Delivery - $2,500
   Corporate License - $5,000
   Online Download plus 1 Hard Copy - $2,750


Loading...
Published Oct 1, 2002 | 130 Pages | Pub ID: KLI758368

Buy more than one volume in the series and save 10-20%
The market for pharmaceuticals targeted to treat human fungal infections is poised to experience strong growth over the next few years. This report from Kalorama Information provides details and insight into the current $4+ billion worldwide market for anti-fungal treatments and the near 10% annual growth that will move the market in the near term.

Among the issues spurring growth is an aging population that is increasing the demand for medicines, including anti-fungal drugs, that will improve their lives as they grow older. In addition, the market is currently under-treated and underserved by existing anti-fungals, mainly in the amphotericin and a variety of azoles. Developing new successful and potent anti-fungal medications remains challenging, and the hunt has been underway for new therapeutics that will be able to improve efficacy, avoid multiple drug interactions, and offer an improved safety profile. Many drugs on the verge of the commercial market purport to achieve of these objectives. Optimizing their mode of delivery will help optimize their activity and reduce costs for the developer.

This report offers an overview of the world anti-fungal market, including insight into the anti-fungal activities of the major players such as Pfizer, Johnson & Johnson, Merck, Novartis, and others. It also examines the efforts of smaller companies that are developing their own niches, and which may be the source for many more effective anti-fungal therapies. The report forecasts the world market for anti-fungal therapies through 2006 and offers details on specific segments of the market. In addition, the report examines patent and exclusivity expiration timing and issues for many key anti-fungal pharmaceuticals.

The World Market for Anti-fungal Medications represents the first volume in Kalorama’s ongoing three-volume study of worldwide anti-infective markets. Subsequent volumes will cover antibacterial and antiviral markets.

Don't forget to check out Volumes II and III of this exciting series! Purchase two volumes and save 10% or purchase the entire series and save 20%!

Volume II: The World Market for Antibacterial Medications

Volume III: The World Market for Antiviral Medications

The World Market for Anti-Infectives Series: Volumes I-III

Executive Summary

    Perspective on Anti-Infective Pharmaceuticals

    Scope and Methodology

    Market Orientation

    • Market Segments
    • Market Segments
    • Major Market Drugs
    • Major Market Players
    • Major Pipeline Therapies
    • Market Expectations

    Issues Driving the Market Place

    Pharmaceutical Challenge

    • Drug Discovery
    • Slow-Evolving Therapies

Introduction

    Common Fungal Infection and Disease
    • Aspergillosis
    • Blastomycosis
    • Candidiasis
    • Cryptococcosis
    • Histoplasmosis
    • Diseases with Fungal Implications—AIDS

    Types of Infection

    Types of Therapies

    Infection Trends

    • HIV and AIDS
    • Sepsis
    • Children
    • Oropharyngeal Candidiasis
    • Onychomycosis
    • Mycoses

    Epidemiologic Summary

    Issues Facing Developers

    • Immunocompromised and Immunosuppressed Patients
    • Overprescribing and Drug Resistance

Emerging Therapies

    The Need for Antifungal Drugs

    Drug Patent and Exclusivity Expirations

    Antifungal Therapies under Development

    • Research Activity
    • Amphotericin B
    • Extending Current Therapies
    • Optimizing Pharmaceutical Delivery

The Market for Antifungal Pharmaceuticals

    World Market Overview

    A Growth Industry

    Market Issues

    • Generic Competition
    • OTC Switches

    Competitive Analysis

    Markets by Geographic Region

    Markets for Dermatologic Indications

    • U.S. Market
    • European Market
    • Japanese Market
    • Rest of World Market

    Markets for Nondermatologic Indications

    Miscellaneous Market Notes

    • Onychomycosis
    • Related Drug Delivery Market

Corporate Profiles

  • AM-Pharma BV
  • Aronex Pharmaceuticals Inc.
  • Aventis Pharma AG
  • Bentley Pharmaceuticals Inc.
  • Bristol-Myers Squibb Co.
  • Ecopia BioSciences Inc.
  • Elan Corp. plc
  • Fujisawa Healthcare Inc.
  • Genome Therapeutics Corp.
  • Gilead Sciences Inc.
  • GPC Biotec AG
  • Immtech International Inc.
  • Intrabiotics Pharmaceuticals Inc.
  • Isis Innovation Ltd.
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Mylan Laboratories Inc.
  • Novartis International AG
  • Oxford GlycoSciences Ltd.
  • Pfizer Inc.
  • Prolifix Ltd.
  • Sankyo Co. Ltd.
  • Versicor Inc.

List of Exhibits

List of Tables

  • Table 2-1: Fungal Infections: Sources and Traditional Treatments
  • Table 2-2: Factors Contributing to Increased Prevalence of Fungal Infections
  • Table 2-3: Annual Incidence of Selected Fungal Infections in the United States, 2001
  • Table 3-1: Exclusivity Expirations for Key Antifungal Pharmaceuticals
  • Table 3-2: Patent Expirations for Key Antifungal Pharmaceuticals
  • Table 3-3: Selected Antifungal Therapies in the Pipeline
  • Table 3-4: Benefits of Alternative Drug Delivery Technologies
  • Table 4-1: The World Market for Anti-Infective Medications
  • Table 4-2: The World Market for Antifungal Medications
  • Table 4-3: Antifungal Prescription Drugs Now OTC Products
  • Table 4-4: Future Antifungal Prescription Drug Switches to OTC Status
  • Table 4-5: World Market for Antifungal Medications, Sales of Top Selling Products, 2001
  • Table 4-6: World Anti-infective Drug Market, Percentage Shares of the Top-Selling Antifungal Drugs, 2001
  • Table 4-7: World Market for Antifungal Medications, Sales of Top Selling Products, 2006
  • Table 4-8: The U.S. Market for Antifungal Medications, 2002-2006
  • Table 4-9: The European Market for Antifungal Medications, 2002-2006
  • Table 4-10: The South American Market for Antifungal Medications, 2002-2006
  • Table 4-11: The Japanese-Asian Market for Antifungal Medications, 2002-2006
  • Table 4-12: The African Market for Antifungal Medications, 2002-2006
  • Table 4-13: The Global Market Prescription Antifungal Dermatologic Drugs by Type, 2002-2006
  • Table 4-14: The U.S. Market for Prescription Antifungal Dermatologic Drugs, 2002-2006
  • Table 4-15: European Market for Prescription Antifungal Dermatologic Drugs, 2002-2006
  • Table 4-16: Japanese Market for Prescription Antifungal Dermatologic Drugs, 2002-2006
  • Table 4-17: Rest of World Prescription Antifungal Dermatologic Drugs, 2002-2006
  • Table 4-18: The World Market for Nondermatolgic Antifungal Medications, 2002-2006
  • Table 4-19: The U.S. Market for Nondermatolgic Antifungal Medications, 2002-2006
  • Table 4-20: The European Market for Nondermatolgic Antifungal Medications, 2002-2006
  • Table 4-21: The Japanese-Asian Market for Nondermatologic Antifungal Medications, 2002-2006
  • Table 4-22: The South American-African-ROW Market for Nondermatologic Antifungal Medications, 2002-2006

List of Figures

  • Figure 1-1: World Anti-Infective Drug Market by Type and Distribution Channel
  • Figure 2-1: Efficacy of CPE-125-Enhanced Clotrimazole Compared with Clotrimazole Alone
  • Figure 4-1: World Antifungal Drug Market by Type of Drug, 2002 and 2006
  • Figure 4-2: Incidence of Selected Oral Fungal Infections, 2000 and 2012
  • Figure 4-3: World Antifungal Drug Market, Market Shares of Top Competitors, 2001

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.